(Q44438446)

3 December 2017

title

Use of rapamycin slows progression of cardiac transplantation vasculopathy (English)

1 reference

3 December 2017

Use of Rapamycin Slows Progression of Cardiac Transplantation Vasculopathy (English)

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000070421.38604.2B

1 January 2024

1 reference

Cardiology and cardiovascular medicine

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000070421.38604.2B

1 January 2024

2

Sean Pinney

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12742978

1 January 2024

1

Donna Mancini

1 reference

3 December 2017

Daniel Burkhoff

3

1 reference

3 December 2017

John LaManca

4

1 reference

3 December 2017

Silviu Itescu

5

1 reference

3 December 2017

Elizabeth Burke

6

1 reference

3 December 2017

Niloo Edwards

7

1 reference

3 December 2017

Mehmet Oz

8

1 reference

3 December 2017

Andrew R. Marks

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12742978

1 January 2024

language of work or name

English

0 references

publication date

12 May 2003

1 reference

3 December 2017

1 reference

3 December 2017

volume

108

1 reference

3 December 2017

issue

1

1 reference

3 December 2017

page(s)

48-53

1 reference

Direct and indirect recognition: the role of MHC antigens in graft rejection

3 December 2017

cites work

3

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000070421.38604.2B

Viral triggers of cardiac-allograft dysfunction

1 January 2024

4

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000070421.38604.2B

Rapamycin inhibits vascular smooth muscle cell migration

1 January 2024

7

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000070421.38604.2B

Rapamune® (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression

1 January 2024

8

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000070421.38604.2B

Rapamycin reverses chronic graft vascular disease in a novel cardiac allograft model

1 January 2024

9

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000070421.38604.2B

Rapamycin resistance tied to defective regulation of p27Kip1.

1 January 2024

12

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000070421.38604.2B

Immunosuppressive effects and safety of a sirolimus/cyclosporine combination regimen for renal transplantation

1 January 2024

14

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000070421.38604.2B

Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group

1 January 2024

15

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000070421.38604.2B

Cardiac transplant coronary artery disease. A multivariable analysis of pretransplantation risk factors for disease development and morbid events.

1 January 2024

17

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000070421.38604.2B

An immunological algorithm to predict risk of high-grade rejection in cardiac transplant recipients

1 January 2024

19

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000070421.38604.2B

An intravascular ultrasound study of the influence of angiotensin-converting enzyme inhibitors and calcium entry blockers on the development of cardiac allograft vasculopathy

1 January 2024

21

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000070421.38604.2B

Efficacy of augmented immunosuppressive therapy for early vasculopathy in heart transplantation

1 January 2024

22

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000070421.38604.2B

A preliminary study of diltiazem in the prevention of coronary artery disease in heart-transplant recipients

1 January 2024

23

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000070421.38604.2B

Effect of pravastatin on outcomes after cardiac transplantation.

1 January 2024

24

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000070421.38604.2B

Simvastatin reduces graft vessel disease and mortality after heart transplantation: a four-year randomized trial

1 January 2024

25

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000070421.38604.2B

Contribution of direct and indirect recognition pathways to T cell alloreactivity

1 January 2024

26

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000070421.38604.2B

Indirect recognition of donor HLA-DR peptides in organ allograft rejection

1 January 2024

27

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000070421.38604.2B

New strategies for early diagnosis of heart allograft rejection

1 January 2024

28

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000070421.38604.2B

1 January 2024

Epitope spreading

29

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000070421.38604.2B

Do B cells drive the diversification of immune responses?

1 January 2024

31

1 reference

https://api.crossref.org/works/10.1161/01.CIR.0000070421.38604.2B

1 January 2024

Identifiers

1 reference

3 December 2017

1 reference